[Treatment of invasive fungal infections. 2005. Andalusian Infectious Disease Society].
Invasive fungal infections have increased progressively in the last decades, producing elevated morbidity and mortality. In recent years, there have been numerous advances in the treatment of these diseases, with the introduction of new drugs in clinical practice and the information derived from several types of studies. This has improved the prognosis of some invasive fungal infections and increased the therapeutic options in various clinical situations. This new knowledge must be assessed to determine its application in clinical practice, taking into account available scientific evidence and clinical experience. With this aim, the Andalusian Society of Infectious Diseases has developed this consensus document containing recommendations for the treatment of the invasive fungal infections.
Pachón
Jerónimo
J
Sociedad Andaluza de Enfermedades Infecciosas, Hospitales Universitarios Virgen del Rocio, Avda. Manuel Siurot s/n, 41013 Seville, Spain. jeronimo.pachon.sspa@ juntadeandalucia.es
Cisneros
José Miguel
JM
Collado-Romacho
Antonio Ramón
AR
Lomas-Cabezas
José Manuel
JM
Lozano de León-Naranjo
Fernando
F
Parra-Ruiz
Jorge
J
Rivero-Román
Antonio
A
D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology; D003453:Cryptococcosis / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D015337:Multicenter Studies as Topic; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000601:surgery / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
D000935:Antifungal Agents